Originalbeitrag in Fachzeitschrift
Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics.
Adanitsch F, Shi J, Shao F, Beyaert R, Heine H, Zamyatina A. Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics. Chemical Science. 2018;9(16):3957-63. doi:https://doi.org/10.1039/c7sc05323a
Externe Links und Eigenschaften der Publikation:
BOKU Autor*innen
Alla Zamyatina
Assoc. Prof. Dipl.-Ing.Dr. Alla Zamyatina
Florian Adanitsch
Dipl.-Ing. Florian Adanitsch
